CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 64 filers reported holding CHEMOCENTRYX INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,908,000 | -8.1% | 95,777 | +11.1% | 0.01% | -11.1% |
| Q4 2020 | $5,338,000 | +34.4% | 86,213 | +18.9% | 0.01% | +12.5% |
| Q3 2020 | $3,973,000 | +222.2% | 72,507 | +238.4% | 0.01% | +166.7% |
| Q2 2020 | $1,233,000 | +468.2% | 21,425 | -28.1% | 0.00% | +200.0% |
| Q1 2017 | $217,000 | -87.6% | 29,800 | -87.3% | 0.00% | -75.0% |
| Q4 2016 | $1,743,000 | +43.6% | 235,484 | +17.2% | 0.00% | +33.3% |
| Q3 2016 | $1,214,000 | +34.6% | 201,000 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $902,000 | +80.4% | 201,000 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $500,000 | -69.3% | 201,000 | 0.0% | 0.00% | -75.0% |
| Q4 2015 | $1,628,000 | +33.9% | 201,000 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $1,216,000 | -26.5% | 201,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,654,000 | +9.0% | 201,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,518,000 | +10.6% | 201,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,373,000 | +51.9% | 201,000 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $904,000 | -23.1% | 201,000 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $1,176,000 | -11.8% | 201,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,333,000 | +15.1% | 201,000 | +0.5% | 0.00% | 0.0% |
| Q4 2013 | $1,158,000 | +4.1% | 200,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,112,000 | -60.7% | 200,000 | 0.0% | 0.00% | -62.5% |
| Q2 2013 | $2,828,000 | – | 200,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |